01 1Orgapharm
01 1Dong-A ST Co., Ltd.
01 1Imiquimod
01 1France
Registrant Name : Dong-A ST Co., Ltd.
Registration Date : 2023-02-15
Registration Number : 20230215-209-J-1446
Manufacturer Name : Orgapharm
Manufacturer Address : Zone Industrielle, Rue du Moulin De La Canne, Pithiviers, 45300, France
95
PharmaCompass offers a list of Imiquimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Imiquimod manufacturer or Imiquimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imiquimod manufacturer or Imiquimod supplier.
A Vyloma manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vyloma, including repackagers and relabelers. The FDA regulates Vyloma manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vyloma API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vyloma manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Vyloma supplier is an individual or a company that provides Vyloma active pharmaceutical ingredient (API) or Vyloma finished formulations upon request. The Vyloma suppliers may include Vyloma API manufacturers, exporters, distributors and traders.
click here to find a list of Vyloma suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vyloma Drug Master File in Korea (Vyloma KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vyloma. The MFDS reviews the Vyloma KDMF as part of the drug registration process and uses the information provided in the Vyloma KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vyloma KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vyloma API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vyloma suppliers with KDMF on PharmaCompass.
